Tevogen Bio Holdings (TVGN) Total Non-Current Liabilities (2022 - 2026)

Tevogen Bio Holdings has reported Total Non-Current Liabilities for 5 years, with the latest figure at $14.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 25.96% year-over-year to $14.8 million; the trailing twelve-month figure through Mar 2026 stood at $14.8 million (up 25.96% YoY), and the FY2025 full-year result was $12.6 million, up 25.3% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $14.8 million, up from $12.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $99.7 million in Q4 2023, with the low at -$3.1 million in Q2 2024.
• Historically, Total Non-Current Liabilities has averaged $17.3 million across 5 years, with a median of $12.3 million in 2025.
• Annual changes were most pronounced in 2023 — Total Non-Current Liabilities surged 567.47% — and 2024, when it sank 118.88%.
• Tevogen Bio Holdings' Total Non-Current Liabilities stood at $14.9 million in 2022, then surged by 567.47% to $99.7 million in 2023, then tumbled by 89.92% to $10.0 million in 2024, then grew by 25.3% to $12.6 million in 2025, then gained by 17.24% to $14.8 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $14.8 million (Q1 2026), $12.6 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.